Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Agitation Article
This is a selection made from among articles on Drug Treatment Agitation. For a permanent link to this article, or to bookmark it for future reading, click here.
Hispanic & Latino Community Treatment
from: Addiction can be described as a physical and mental dependence on any substance, narcotics or otherwise to carry out normal activities of daily life. The addict is not left with a choice and feels compelled to take the drug to sooth that irrepressible craving, despite being aware of the negative long term consequences of drug abuse. There are several physical, metal, financial and social problems attached to the addiction. One starts spending a lot of time procuring, using and recovering from the drug. As result the person is unable to fulfill his social obligations and starts underperforming in school or office. They no longer enjoy doing things that they normally enjoyed like hobbies, playing sports, socializing etc. But the biggest problem are the severe withdrawal symptoms like nausea, insomnia, sweating and anxiety the person experiences the moment he/she tries reduce the usage of the drug. The ethnic label Hispanic is used to describe anyone with a Spanish speaking, Latin American background. The United States is home to millions of Latin American people who have infused the nation with richness and cultural diversity. Keeping in mind the cultural and linguistic differences of Hispanics, Lakeview (www.lakeviewhealth.com) has introduced a special program Tradiciones, which provides drug addiction, alcoholism and dual diagnosis treatment for the Latin American community.
Tradiciones is a Hispanic and Latino rehab facility that is staffed by people who speak fluent Spanish. The doctors and support staffs are from Latin American background and hence are better able to understand the challenges faced by the Hispanic and Latin American people seeking recovery from drug addiction. The combination of a relaxed environment, sympathetic and efficient staff and a high tech clinical care program has made the Hispanic & Latino Rehab course very popular with the community. In Tradiciones each patient is provided with a compulsory and comprehensive psychiatric evaluation that allows our doctors to accurately evaluate his/her mental and emotional state. After the preliminary psychiatric evaluation the patient is treated to individual and group therapy and is made to participate in a number of recreational courses. This is a part of the relapse prevention program and it helps the patient to cope with the stresses of withdrawal. Then the patients are encouraged to participate in four day family recovery program that aids the recuperation processes by accentuating in them the desire to recover.
Please visit us at www.lakeviewhealth.com for any further information you may need on our Hispanic and Latino rehab program.
About Author
Paul Giller is very well known author, who writes on Drug Addiction treatment, detox services,drug rehab service, dual dignosis services etc. for more details visit www.lakeviewhealth.com.
Source: ArticleTrader.com
Drug Treatment Agitation Specific links
Drug Treatment Agitation News
Alzheimer's drug fails to reduce significant agitation
A drug prescribed for Alzheimer's disease does not ease clinically significant agitation in patients, according to first randomized controlled trial designed to assess the effectiveness of the drug (generic name memantine) for significant agitation in Alzheimer's patients.
Read more...Alexza Pharma receives complete response letter for Adasuve NDA
Alexza Pharmaceuticals announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for ADASUVE inhalation powder, 5 mg and 10 ...
Read more...Abbott Laboratories Guilty of Fraud, Ordered to Pay $1.5 Billion
In what the Justice Department has declared to be one of the largest payments by a drug company in U.S. history, Abbott Laboratories was ordered on Monday to pay a combination of criminal fines and civil settlements totaling more than $1.5 billion. The company previously pleaded guilty to marketing its drug Depakote for uses which the Food and Drug Administration had not approved, according to ...
Read more...Alexza Receives Complete Response Letter for Adasuve™ NDA
MOUNTAIN VIEW, Calif., May 3, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (ALXA) announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration ...
Read more...Drug misbranding leads to $1.5B fine
Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote, the U.S. Justice Department announced Monday.
Read more...Abbott Laboratories to pay $1.6 billion over misbranding drug
Abbott Laboratories has pleaded guilty and agreed to pay $1.6 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote, the U.S. Justice Department said Monday. Acting Associate Attorney General Tony West said it was case of Abbott putting "profits ahead of patients." The total includes a criminal fine of $700 million and ...
Read more...Abbott Laboratories pays $1.5 million over misbranding drug
Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote, the U.S. Justice Department announced Monday.
Read more...26 Drugs Facing FDA Approval in 2012
An updated calendar listing FDA drug approval decisions and advisory panels for the remainder of 2012. Click to view a price quote on REGN . Click to research the Drugs industry.
Read more...Oregon in Record $100 Million Drug Settlement
Oregon Attorney General John Kroger announced Monday a $100 million multi-state agreement with global health care and medical research company Abbott Laboratories over off-label promotional claims related to its drug Depakote®. This agreement marks the largest ever consumer protection-based pharmaceutical settlement.
Read more...Information Update - Antidepressant Cipralex (escitalopram): Updated information regarding dose-related heart risk
OTTAWA, May 7, 2012 /CNW/ - Health Canada is informing Canadians of a labelling update for the prescription drug Cipralex (the brand name of the drug escitalopram) regarding a dose-related risk of abnormal ...
Read more...